| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/S0065-2318(01)57017-1 |
| P698 | PubMed publication ID | 11836942 |
| P2093 | author name string | B Casu | |
| U Lindahl | |||
| P2860 | cites work | Requirement for anticoagulant heparan sulfate in the fibroblast growth factor receptor complex | Q78037697 |
| Negative ion fast-atom bombardment tandem mass spectrometry to determine sulfate and linkage position in glycosaminoglycan-derived disaccharides | Q86746086 | ||
| A force-field study of the conformational characteristics of the iduronate ring | Q89354825 | ||
| High-performance liquid chromatographic separation of heparin-derived oligosaccharides | Q93681630 | ||
| Human heparanase. Purification, characterization, cloning, and expression | Q22003728 | ||
| Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis | Q22010222 | ||
| Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization | Q24290400 | ||
| Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin | Q24290496 | ||
| Molecular cloning and expression of human UDP-d-Xylose:proteoglycan core protein beta-d-xylosyltransferase and its first isoform XT-II | Q24290566 | ||
| The putative tumour suppressor EXT1 alters the expression of cell-surface heparan sulfate | Q24323532 | ||
| The EXT1/EXT2 tumor suppressors: catalytic activities and role in heparan sulfate biosynthesis | Q24522477 | ||
| N.m.r. and molecular-modelling studies of the solution conformation of heparin | Q24528140 | ||
| Molecular distinctions between heparan sulphate and heparin. Analysis of sulphation patterns indicates that heparan sulphate and heparin are separate families of N-sulphated polysaccharides | Q24529894 | ||
| Structural basis and potential role of heparin/heparan sulfate binding to the angiogenesis inhibitor endostatin | Q24529922 | ||
| Structural differences and the presence of unsubstituted amino groups in heparan sulphates from different tissues and species | Q24530061 | ||
| cDNA cloning, genomic organization and chromosomal localization of human heparan glucosaminyl N-deacetylase/N-sulphotransferase-2 | Q24530865 | ||
| Expression of heparan sulphate L-iduronyl 2-O-sulphotransferase in human kidney 293 cells results in increased D-glucuronyl 2-O-sulphation | Q24531959 | ||
| The intact and cleaved human antithrombin III complex as a model for serpin–proteinase interactions | Q27729838 | ||
| Biological implications of a 3 A structure of dimeric antithrombin | Q27730918 | ||
| Heparin structure and interactions with basic fibroblast growth factor | Q27732601 | ||
| Structure of a heparin-linked biologically active dimer of fibroblast growth factor | Q27760195 | ||
| Molecular cloning and expression of a third member of the heparan sulfate/heparin GlcNAc N-deacetylase/ N-sulfotransferase family | Q28118805 | ||
| Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis | Q28138868 | ||
| Heparan sulfate D-glucosaminyl 3-O-sulfotransferase-3A sulfates N-unsubstituted glucosamine residues | Q28141121 | ||
| A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry | Q28145858 | ||
| Multivalent Ligand-Receptor Binding Interactions in the Fibroblast Growth Factor System Produce a Cooperative Growth Factor and Heparin Mechanism for Receptor Dimerization | Q71642294 | ||
| Polydispersity in sulfation profile of oligosaccharide alditols isolated from the protein-linkage region and the repeating disaccharide region of chondroitin 4-sulfate of bovine nasal septal cartilage | Q71652972 | ||
| Rational design of synthetic heparin analogues with tailor-made coagulation factor inhibitory activity | Q71727041 | ||
| Perlecan: a gem of a proteoglycan | Q28238298 | ||
| Integral membrane heparan sulfate proteoglycans | Q28262453 | ||
| Substrate specificity of heparanases from human hepatoma and platelets | Q28276774 | ||
| Regulated diversity of heparan sulfate | Q28282444 | ||
| Conformer populations of L-iduronic acid residues in glycosaminoglycan sequences | Q28283247 | ||
| The putative tumor suppressors EXT1 and EXT2 are glycosyltransferases required for the biosynthesis of heparan sulfate | Q28284035 | ||
| Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation | Q28296150 | ||
| Conformation of heparin pentasaccharide bound to antithrombin III | Q28360842 | ||
| Common binding sites for beta-amyloid fibrils and fibroblast growth factor-2 in heparan sulfate from human cerebral cortex | Q28374326 | ||
| Specificities of heparan sulphate proteoglycans in developmental processes | Q28377841 | ||
| Abnormal mast cells in mice deficient in a heparin-synthesizing enzyme | Q28586968 | ||
| Targeted disruption of NDST-1 gene leads to pulmonary hypoplasia and neonatal respiratory distress in mice | Q28589567 | ||
| Multiple isozymes of heparan sulfate/heparin GlcNAc N-deacetylase/GlcN N-sulfotransferase. Structure and activity of the fourth member, NDST4 | Q28591320 | ||
| The occurrence of three isoforms of heparan sulfate 6-O-sulfotransferase having different specificities for hexuronic acid adjacent to the targeted N-sulfoglucosamine | Q28594700 | ||
| Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor | Q29616189 | ||
| Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate | Q29618060 | ||
| Functions of cell surface heparan sulfate proteoglycans | Q29618521 | ||
| Angiogenic factors | Q29620582 | ||
| Synthesis of thrombin-inhibiting heparin mimetics without side effects | Q30573078 | ||
| Sequencing complex polysaccharides | Q30791276 | ||
| Structure of heparin-derived tetrasaccharide complexed to the plasma protein antithrombin derived from NOEs, J-couplings and chemical shifts | Q31271143 | ||
| Mass spectrometric evidence for the enzymatic mechanism of the depolymerization of heparin-like glycosaminoglycans by heparinase II. | Q32000531 | ||
| Heparan sulfate oligosaccharides require 6-O-sulfation for promotion of basic fibroblast growth factor mitogenic activity | Q32030968 | ||
| Generation and application of type-specific anti-heparan sulfate antibodies using phage display technology. Further evidence for heparan sulfate heterogeneity in the kidney | Q32064386 | ||
| Direct evidence for a predominantly exolytic processive mechanism for depolymerization of heparin-like glycosaminoglycans by heparinase I. | Q32068517 | ||
| Ion-spray mass spectrometric analysis of glycosaminoglycan oligosaccharides. | Q33429751 | ||
| Pharmacokinetic and pharmacodynamic properties of oral anticoagulants, especially phenprocoumon | Q33635030 | ||
| Heparin in inflammation: potential therapeutic applications beyond anticoagulation. | Q33637649 | ||
| The elusive functions of proteoglycans: in vivo veritas | Q33825069 | ||
| Overexpression of different isoforms of glucosaminyl N-deacetylase/N-sulfotransferase results in distinct heparan sulfate N-sulfation patterns | Q33897548 | ||
| Selectively desulfated heparin inhibits fibroblast growth factor-induced mitogenicity and angiogenesis | Q33902258 | ||
| Heparin and heparan sulfate: biosynthesis, structure and function | Q33927046 | ||
| Molecular structure of the carbohydrate-protein linkage region fragments from connective-tissue proteoglycans | Q34064621 | ||
| Conformation and dynamics of heparin and heparan sulfate | Q34087654 | ||
| Signal transduction by allosteric receptor oligomerization | Q34165171 | ||
| Isolation and characterization of hexasaccharides derived from heparin. Analysis by HPLC and elucidation of structure by 1H NMR | Q72112565 | ||
| Preparation and structural characterization of large heparin-derived oligosaccharides | Q72292508 | ||
| Energetic characterization of the basic fibroblast growth factor-heparin interaction: identification of the heparin binding domain | Q72326632 | ||
| The effect of variation of substitution on the solution conformation of heparin: a spectroscopic and molecular modelling study | Q72414841 | ||
| Structural studies on the oligosaccharides isolated from bovine kidney heparan sulphate and characterization of bacterial heparitinases used as substrates | Q72423520 | ||
| Substrate specificity of the heparin lyases from Flavobacterium heparinum | Q72545221 | ||
| "Fast moving" and "slow moving" heparins, dermatan sulfate, and chondroitin sulfate: qualitative and quantitative analysis by agarose-gel electrophoresis | Q72559654 | ||
| Structure of heparan sulfate from the fresh water mollusc Anomantidae sp: sequencing of its disaccharide units | Q72565706 | ||
| Characterization of the chemical structure of sulphated glycosaminoglycans after enzymatic digestion. Application of liquid chromatography-mass spectrometry with an atmospheric pressure interface | Q72572617 | ||
| Thermodynamics of charged oligopeptide-heparin interactions | Q72638505 | ||
| Separation of glycosaminoglycan-derived oligosaccharides by capillary electrophoresis using reverse polarity | Q72870539 | ||
| FABMS/derivatisation strategies for the analysis of heparin-derived oligosaccharides | Q72873336 | ||
| Sulfated Oligosaccharides Isolated from the Deamination Products of Heparins1 | Q72908972 | ||
| New insights on the specificity of heparin and heparan sulfate lyases from Flavobacterium heparinum revealed by the use of synthetic derivatives of K5 polysaccharide from E. coli and 2-O-desulfated heparin | Q73223170 | ||
| Preparation and structure of heparin lyase-derived heparan sulfate oligosaccharides | Q73304927 | ||
| Direct isolation and sequencing of specific protein-binding glycosaminoglycans | Q73339920 | ||
| Specific binding of the chemokine platelet factor 4 to heparan sulfate | Q73575394 | ||
| Partial purification and substrate specificity of heparan sulfate alpha-N-acetylglucosaminyltransferase I: synthesis, NMR spectroscopic characterization and in vitro assays of two aryl tetrasaccharides | Q73579678 | ||
| Role of arginine 129 in heparin binding and activation of antithrombin | Q73675879 | ||
| Amyloid-specific heparan sulfate from human liver and spleen | Q73797107 | ||
| Preparation of completely 6-O-desulfated heparin and its ability to enhance activity of basic fibroblast growth factor | Q73850106 | ||
| Fibroblast growth factors and their receptors | Q74584667 | ||
| Characterization of heparin oligosaccharide mixtures as ammonium salts using electrospray mass spectrometry | Q74604046 | ||
| Determination of the structure of oligosaccharides prepared from acharan sulfate | Q74801759 | ||
| The putative heparin-specific N-acetylglucosaminyl N-Deacetylase/N-sulfotransferase also occurs in non-heparin-producing cells | Q77126990 | ||
| Conversion of N-sulfated glucosamine to N-sulfated mannosamine in an unsaturated heparin disaccharide by non-enzymatic, base-catalyzed C-2 epimerization during enzymatic oligosaccharide preparation | Q77317037 | ||
| Microanalysis of glycosaminoglycan-derived oligosaccharides labeled with a fluorophore 2-aminobenzamide by high-performance liquid chromatography: application to disaccharide composition analysis and exosequencing of oligosaccharides | Q77380362 | ||
| Characterization of fibroblast growth factor 1 binding heparan sulfate domain | Q77856163 | ||
| Combined NMR and molecular modeling study of an iduronic acid-containing trisaccharide related to antithrombotic heparin fragments | Q38344398 | ||
| Endothelial cell heparanase modulation of lipoprotein lipase activity. Evidence that heparan sulfate oligosaccharide is an extracellular chaperone | Q38344887 | ||
| Glycosaminoglycans can influence fibroblast growth factor-2 mitogenicity without significant growth factor binding | Q38344902 | ||
| Properly oriented heparin-decasaccharide-induced dimers are the biologically active form of basic fibroblast growth factor. | Q38346690 | ||
| Characterization of heparin and heparan sulfate domains binding to the long splice variant of platelet-derived growth factor A chain | Q38348282 | ||
| Conformation of the pentasaccharide corresponding to the binding site of heparin to antithrombin-III. | Q38349007 | ||
| Enzymatic preparation of heparin oligosaccharides containing antithrombin III binding sites | Q38350614 | ||
| Domain structure of proteoheparan sulphate from confluent cultures of human embryonic skin fibroblasts | Q38351842 | ||
| Sequence variation in heparin octasaccharides with high affinity for antithrombin III. | Q38353259 | ||
| An animal cell mutant defective in heparan sulfate hexuronic acid 2-O-sulfation | Q38355072 | ||
| Structure and biological activity of finback-whale (Balaenoptera physalus L.) heparin octasaccharide. Chemical, carbon-13 nuclear-magnetic-resonance, enzymic and biological studies | Q38355332 | ||
| Structures of five sulfated hexasaccharides prepared from porcine intestinal heparin using bacterial heparinase. Structural variants with apparent biosynthetic precursor-product relationships for the antithrombin III-binding site | Q38358031 | ||
| Conformational flexibility: a new concept for explaining binding and biological properties of iduronic acid-containing glycosaminoglycans | Q39579344 | ||
| Polysaccharide lyases | Q39735604 | ||
| Structure and biological activity of heparin. | Q39841200 | ||
| More to "heparin" than anticoagulation | Q40695910 | ||
| Substrate specificity of the heparan sulfate hexuronic acid 2-O-sulfotransferase | Q40809157 | ||
| Glycosaminoglycans and the regulation of blood coagulation | Q40851193 | ||
| Regulation of growth factor activation by proteoglycans: what is the role of the low affinity receptors? | Q40922726 | ||
| Involvement of the core protein in the first beta-N-acetylgalactosamine transfer to the glycosaminoglycan-protein linkage-region tetrasaccharide and in the subsequent polymerization: the critical determining step for chondroitin sulphate biosynthesi | Q40953551 | ||
| Monomer complexes of basic fibroblast growth factor and heparan sulfate oligosaccharides are the minimal functional unit for cell activation | Q40957417 | ||
| Heparan sulphate and protein recognition. Binding specificities and activation mechanisms. | Q40967487 | ||
| Heparan sulfate: a piece of information | Q41135360 | ||
| Alternatively spliced juxtamembrane domain of a tyrosine kinase receptor is a multifunctional regulatory site. Deletion alters cellular tyrosine phosphorylation pattern and facilitates binding of phosphatidylinositol-3-OH kinase to the hepatocyte gr | Q41380865 | ||
| Biosynthesis of heparin. Use of Escherichia coli K5 capsular polysaccharide as a model substrate in enzymic polymer-modification reactions | Q41814747 | ||
| Very-high-field n.m.r. studies of bovine lung heparan sulphate tetrasaccharides produced by nitrous acid deaminative cleavage. Determination of saccharide sequence, uronate composition and degrees of sulphation | Q41816735 | ||
| Binding of the G domains of laminin alpha1 and alpha2 chains and perlecan to heparin, sulfatides, alpha-dystroglycan and several extracellular matrix proteins | Q42001102 | ||
| Biosynthesis of heparin. Relationship between the polymerization and sulphation processes | Q42005884 | ||
| Fractionation of heparin-derived oligosaccharides by gradient polyacrylamide-gel electrophoresis | Q42047718 | ||
| Structure of heparan sulphate from human brain, with special regard to Alzheimer's disease | Q42160698 | ||
| Distribution of iduronate 2-sulphate residues in heparan sulphate. Evidence for an ordered polymeric structure | Q42161980 | ||
| Further characterization of the antithrombin-binding sequence in heparin | Q42263887 | ||
| Heparan sulfate degradation: relation to tumor invasive and metastatic properties of mouse B16 melanoma sublines | Q42450178 | ||
| Human platelet heparanase: purification, characterization and catalytic activity | Q42451905 | ||
| Domain structure of heparan sulfates from bovine organs | Q42555942 | ||
| Structure of heparin-derived tetrasaccharides | Q42670467 | ||
| A major common trisulfated hexasaccharide core sequence, hexuronic acid(2-sulfate)-glucosamine(N-sulfate)-iduronic acid-N-acetylglucosamine-glucuronic acid-glucosamine(N-sulfate), isolated from the low sulfated irregular region of porcine intestinal | Q42671353 | ||
| Human glucosamine-6-sulphatase deficiency. Diagnostic enzymology towards heparin-derived trisaccharide substrates | Q42792998 | ||
| Mitogenic activity of acidic fibroblast growth factor is enhanced by highly sulfated oligosaccharides derived from heparin and heparan sulfate | Q42807954 | ||
| Highly sensitive sequencing of the sulfated domains of heparan sulfate. | Q42814375 | ||
| Distinct role of 2-O-, N-, and 6-O-sulfate groups of heparin in the formation of the ternary complex with basic fibroblast growth factor and soluble FGF receptor-1. | Q42834483 | ||
| Conformational equilibria of alpha-L-iduronate residues in disaccharides derived from heparin | Q42855754 | ||
| The disaccharide composition of heparins and heparan sulfates | Q43545252 | ||
| Sequence analysis of heparan sulfate epitopes with graded affinities for fibroblast growth factors 1 and 2. | Q43640409 | ||
| Disaccharide compositional analysis of heparin and heparan sulfate using capillary zone electrophoresis | Q43833849 | ||
| The disaccharide repeating-units of heparan sulfate | Q44177045 | ||
| Sulfation of some chemically-modified heparins. Formation of a 3-sulfate analog of heparin | Q44577321 | ||
| One- and two-dimensional 1H-NMR characterization of two series of sulfated disaccharides prepared from chondroitin sulfate and heparan sulfate/heparin by bacterial eliminase digestion | Q44661049 | ||
| 1H-N.m.r. spectral assignments for two series of heparin-derived oligosaccharides. | Q45908212 | ||
| Defining the interleukin-8-binding domain of heparan sulfate | Q38336349 | ||
| Age-dependent modulation of heparan sulfate structure and function | Q38337039 | ||
| Structural modification of fibroblast growth factor-binding heparan sulfate at a determinative stage of neural development | Q38339362 | ||
| Oligosaccharide mapping of low molecular weight heparins: structure and activity differences | Q38340683 | ||
| Interaction of fibroblast growth factor-1 and related peptides with heparan sulfate and its oligosaccharides | Q38342270 | ||
| Structural requirement of heparan sulfate for interaction with herpes simplex virus type 1 virions and isolated glycoprotein C. | Q38342862 | ||
| Chemical sulfonation and anticoagulant activity of acharan sulfate | Q46417968 | ||
| Endothelial heparan sulfate proteoglycans that bind to L-selectin have glucosamine residues with unsubstituted amino groups | Q46519756 | ||
| Turnover of heparan sulfate depends on 2-O-sulfation of uronic acids | Q46699156 | ||
| "Supersulfated" heparin fragments, a new type of low-molecular weight heparin. Physico-chemical and pharmacological properties | Q47194633 | ||
| Assessment through chemical synthesis of the size of the heparin sequence involved in thrombin inhibition | Q47258600 | ||
| Molecular profiling and weight determination of heparins and depolymerized heparins | Q47353379 | ||
| Physiochemical characterization of low molecular weight heparin | Q47359027 | ||
| Molecular weight of low molecular weight heparins by 13C nuclear magnetic resonance spectroscopy | Q47378087 | ||
| Gradient polyacrylamide gel electrophoresis for determination of molecular weights of heparin preparations and low-molecular-weight heparin derivatives | Q47409124 | ||
| Importance of size and sulfation of heparin in release of basic fibroblast growth factor from the vascular endothelium and extracellular matrix | Q47416115 | ||
| FGF signaling in skeletal development. | Q47768464 | ||
| New insights into heparin-induced FGF oligomerization | Q47842142 | ||
| Identification and expression in mouse of two heparan sulfate glucosaminyl N-deacetylase/N-sulfotransferase genes | Q48037516 | ||
| Biosynthesis of heparin/heparan sulfate. cDNA cloning and expression of D-glucuronyl C5-epimerase from bovine lung | Q48043443 | ||
| Reg1ulatory role and molecular interactions of a cell-surface heparan sulfate proteoglycan (N-syndecan) in hippocampal long-term potentiation. | Q48287519 | ||
| Heparin-induced conformational change and activation of mucus proteinase inhibitor. | Q50790111 | ||
| Isolation and recovery of acidic oligosaccharides from polyacrylamide gels by semi-dry electrotransfer | Q50884304 | ||
| Flavobacterium heparinum 2-O-sulphatase for 2-O-sulphato-delta 4,5-glycuronate-terminated oligosaccharides from heparin. | Q50919485 | ||
| Developmental Regulation of Neural Response to FGF-1 and FGF-2 by Heparan Sulfate Proteoglycan | Q52225676 | ||
| FKBP-12 recognition is dispensable for signal generation by type I transforming growth factor-beta receptors. | Q52521102 | ||
| Motional properties of E. coli polysaccharide K5 in aqueous solution analyzed by NMR relaxation measurements. | Q54566015 | ||
| Presence of N-unsubstituted glucosamine units in native heparan sulfate revealed by a monoclonal antibody. | Q54598050 | ||
| Heparin-like compounds prepared by chemical modification of capsular polysaccharide from E. coli K5. | Q54625741 | ||
| Low-sulphated oligosaccharides derived from heparan sulphate inhibit normal angiogenesis. | Q54647861 | ||
| Effect of substitution pattern on 1 H, 13 C NMR chemical shifts and 1 J CH coupling constants in heparin derivatives | Q56833711 | ||
| Evidence for a heparin derivative containing an N-sulfated aziridine ring that retains high anti-factor Xa activity | Q56833712 | ||
| Modifications under basic conditions of the minor sequences of heparin containing 2,3 or 2,3,6 sulfatedd-glucosamine residues | Q56833714 | ||
| Combined Quantitative 1H and 13C Nuclear Magnetic Resonance Spectroscopy for Characterization of Heparin Preparations | Q57563823 | ||
| Conformational analysis of heparin epoxide in aqueous solution. An NMR relaxation study | Q57563854 | ||
| Synthesis of a N′-Alkylamine Anticoagulant Active Low-Molecular-Mass Heparin for Radioactive and Fluorescent Labeling | Q57563874 | ||
| Conformation of the Unsaturated Uronic Acid Residues of Glycosamtnoglycan Disaccharides | Q57563878 | ||
| Purification and characterization of fetal bovine serum beta-N-acetyl-D-galactosaminyltransferase and beta-D-glucuronyltransferase involved in chondroitin sulfate biosynthesis | Q58831352 | ||
| Synthesis and Characterization of Highly Sensitive Heparin Probes for Detection of Heparin-Binding Proteins | Q63944754 | ||
| High-performance liquid chromatographic-mass spectrometric analysis of oligosaccharides from enzymatic digestion of glycosaminoglycans. Application to human samples | Q68171518 | ||
| Heparin-derived oligosaccharides: affinity for acidic fibroblast growth factor and effect on its growth-promoting activity for human endothelial cells | Q69355994 | ||
| Sequence analysis of highly sulfated, heparin-derived oligosaccharides using fast atom bombardment mass spectrometry | Q69715083 | ||
| Study of structurally defined oligosaccharide substrates of heparin and heparan monosulfate lyases | Q69777421 | ||
| N.m.r. spectroscopic observations related to the function of sulfate groups in heparin. Calcium binding vs. biological activity | Q70027267 | ||
| Marked stereoselectivity in the binding of copper ions by heparin. Contrasts with the binding of gadolinium and calcium ions | Q70244333 | ||
| A relationship between 13C-chemical-shift displacements and counterion-condensation theory, in the binding of calcium ion by heparin | Q70373222 | ||
| Isolation and characterization of heparan sulfate from crude porcine intestinal mucosal peptidoglycan heparin | Q70823083 | ||
| A method for rapid quantitation and preparation of antithrombin III--high-affinity heparin fractions | Q71027130 | ||
| Structure-activity relationship in heparin: a synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activity | Q71137899 | ||
| A new glycosaminoglycan from the giant African snail Achatina fulica | Q71142713 | ||
| Strategy for the sequence analysis of heparin | Q71291258 | ||
| Chemical modifications of heparin that diminish its anticoagulant but preserve its heparanase-inhibitory, angiostatic, anti-tumor and anti-metastatic properties | Q71303804 | ||
| Structural studies on heparin. Tetrasaccharides obtained by heparinase degradation | Q71321960 | ||
| Divalent cations and heparin/heparan sulfate cooperate to control assembly and activity of the fibroblast growth factor receptor complex | Q71574049 | ||
| ??? | Q22009535 | ||
| Isolation and characterization of human heparin | Q34279022 | ||
| Toward a biotechnological heparin through combined chemical and enzymatic modification of the Escherichia coli K5 polysaccharide | Q34415381 | ||
| A strategy for rapid sequencing of heparan sulfate and heparin saccharides | Q35059120 | ||
| Isolation and expression in Escherichia coli of hepB and hepC, genes coding for the glycosaminoglycan-degrading enzymes heparinase II and heparinase III, respectively, from Flavobacterium heparinum | Q35192351 | ||
| Cell surface receptors for herpes simplex virus are heparan sulfate proteoglycans | Q36531041 | ||
| Expression in Escherichia coli, purification and characterization of heparinase I from Flavobacterium heparinum | Q36797422 | ||
| Molecular cloning and expression of Chinese hamster ovary cell heparan-sulfate 2-sulfotransferase | Q36861170 | ||
| NMR solution conformation of heparin-derived hexasaccharide | Q36889781 | ||
| Proteoglycans: structures and interactions | Q37285263 | ||
| Genetic analysis of proteoglycan structure, function and metabolism | Q37421925 | ||
| The heparin-binding (fibroblast) growth factor family of proteins | Q38286731 | ||
| Molecular organization of the interferon γ-binding domain in heparan sulphate | Q38292110 | ||
| The activation of fibroblast growth factors by heparin: synthesis, structure, and biological activity of heparin-like oligosaccharides. | Q38292324 | ||
| Structural and functional properties of heparin analogues obtained by chemical sulphation of Escherichia coli K5 capsular polysaccharide | Q38293432 | ||
| FGF binding and FGF receptor activation by synthetic heparan-derived di- and trisaccharides. | Q38296447 | ||
| Structure of heparin fragments with high affinity for lipoprotein lipase and inhibition of lipoprotein lipase binding to alpha 2-macroglobulin-receptor/low-density-lipoprotein-receptor-related protein by heparin fragments | Q38297068 | ||
| Enzymatic degradation of glycosaminoglycans | Q38300252 | ||
| Structural requirements in heparin for binding and activation of FGF-1 and FGF-4 are different from that for FGF-2. | Q38302156 | ||
| Binding of heparin/heparan sulfate to fibroblast growth factor receptor 4. | Q38302571 | ||
| Structural features in heparin which modulate specific biological activities mediated by basic fibroblast growth factor | Q38305985 | ||
| Structural studies on the tri- and tetrasaccharides isolated from porcine intestinal heparin and characterization of heparinase/heparitinases using them as substrates | Q38311533 | ||
| Elucidation of the structural features of heparan sulfate important for interaction with the Hep-2 domain of fibronectin. | Q38315553 | ||
| A novel strategy to generate biologically active neo-glycosaminoglycan conjugates. | Q38318456 | ||
| Nature of the interaction of heparin with acidic fibroblast growth factor | Q38319104 | ||
| Oligosaccharides corresponding to the regular sequence of heparin: chemical synthesis and interaction with FGF-2. | Q38319215 | ||
| A synthetic heparan sulfate pentasaccharide, exclusively containing L-iduronic acid, displays higher affinity for FGF-2 than its D-glucuronic acid-containing isomers | Q38320742 | ||
| Identification of a hexasaccharide sequence able to inhibit thrombin and suitable for 'polymerisation'. | Q38321135 | ||
| Sequence analysis of heparan sulphate and heparin oligosaccharides | Q38325522 | ||
| Structural studies of octasaccharides derived from the low-sulfated repeating disaccharide region and octasaccharide serines derived from the protein linkage region of porcine intestinal heparin | Q38329461 | ||
| Diversity does make a difference: fibroblast growth factor-heparin interactions | Q38331346 | ||
| Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells | Q38331586 | ||
| Heparinase II from Flavobacterium heparinum. HPLC analysis of the saccharides generated from chemically modified heparins | Q38331863 | ||
| Mechanism of heparin activation of antithrombin: evidence for an induced-fit model of allosteric activation involving two interaction subsites | Q38333380 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | heparin | Q190016 |
| P304 | page(s) | 159-206 | |
| P577 | publication date | 2001-01-01 | |
| P1433 | published in | Advances in Carbohydrate Chemistry and Biochemistry | Q15749696 |
| P1476 | title | Structure and biological interactions of heparin and heparan sulfate | |
| P478 | volume | 57 |
| Q48773643 | 'Heparin'--from anticoagulant drug into the new biology |
| Q33230192 | 3-O-sulfated oligosaccharide structures are recognized by anti-heparan sulfate antibody HS4C3. |
| Q38352392 | A microscopic view on the renal endothelial glycocalyx. |
| Q44516950 | A molecular dynamics description of the conformational flexibility of the L-iduronate ring in glycosaminoglycans. |
| Q41442587 | A new sequencing approach for N-unsubstituted heparin/heparan sulfate oligosaccharides |
| Q33824892 | A peptide found by phage display discriminates a specific structure of a trisaccharide in heparin. |
| Q46227915 | A surface plasmon resonance-based solution affinity assay for heparan sulfate-binding proteins |
| Q28818221 | An integrated approach using orthogonal analytical techniques to characterize heparan sulfate structure |
| Q37348874 | Analysis of Drosophila glucuronyl C5-epimerase: implications for developmental roles of heparan sulfate sulfation compensation and 2-O-sulfated glucuronic acid |
| Q90260004 | Analysis of Heparan sulfate/heparin from Colla corii asini by liquid chromatography-electrospray ion trap mass spectrometry |
| Q36311737 | Analysis of the interaction between heparin and follistatin and heparin and follistatin-ligand complexes using surface plasmon resonance. |
| Q33822599 | Anchoring of vascular endothelial growth factor to surface-immobilized heparin on pancreatic islets: implications for stimulating islet angiogenesis |
| Q38289147 | Antithrombin-binding octasaccharides and role of extensions of the active pentasaccharide sequence in the specificity and strength of interaction. Evidence for very high affinity induced by an unusual glucuronic acid residue |
| Q35083201 | Applications of isotopes in advancing structural and functional heparanomics |
| Q33928008 | Binding affinities of vascular endothelial growth factor (VEGF) for heparin-derived oligosaccharides |
| Q46850853 | Biochemical analysis and kinetic modeling of the thermal inactivation of MBP-fused heparinase I: implications for a comprehensive thermostabilization strategy |
| Q31074211 | Biosynthetic oligosaccharide libraries for identification of protein-binding heparan sulfate motifs. Exploring the structural diversity by screening for fibroblast growth factor (FGF)1 and FGF2 binding |
| Q37532995 | Brittlestars contain highly sulfated chondroitin sulfates/dermatan sulfates that promote fibroblast growth factor 2-induced cell signaling |
| Q33285352 | Characterization of anti-heparan sulfate phage display antibodies AO4B08 and HS4E4. |
| Q38308225 | Characterization of heparin-protein interaction by saturation transfer difference (STD) NMR. |
| Q38869704 | Characterization of the antithrombotic fingerprint of the branded and copies of the low-molecular-weight enoxaparin using thrombin generation assay |
| Q47114753 | Cheese as Functional Food: The Example of Parmigiano Reggiano and Grana Padano. |
| Q40625483 | Combining measurements to estimate properties and characterization extent of complex biochemical mixtures; applications to Heparan Sulfate |
| Q34978967 | Comparative assessment of the effects of gender-specific heparan sulfates on mesenchymal stem cells |
| Q47780862 | Conformation of heparin studied with macromolecular hydrodynamic methods and X-ray scattering. |
| Q38312109 | Conformational transitions induced in heparin octasaccharides by binding with antithrombin III. |
| Q42105399 | Control of the heparosan N-deacetylation leads to an improved bioengineered heparin |
| Q38320039 | Cooperative dimerization of fibroblast growth factor 1 (FGF1) upon a single heparin saccharide may drive the formation of 2:2:1 FGF1.FGFR2c.heparin ternary complexes |
| Q24816968 | D-glucuronyl C5-epimerase acts in dorso-ventral axis formation in zebrafish |
| Q45261009 | Distinct substrate specificities of bacterial heparinases against N-unsubstituted glucosamine residues in heparan sulfate |
| Q36052448 | Drosophila heparan sulfate, a novel design |
| Q38324891 | Dynamic properties of biologically active synthetic heparin-like hexasaccharides |
| Q33939401 | Effect of carboxyl-reduced heparin on the growth inhibition of bovine pulmonary artery smooth muscle cells |
| Q34473542 | Effect of the substituents of the neighboring ring in the conformational equilibrium of iduronate in heparin-like trisaccharides |
| Q41138689 | Enriching a cellulose hydrogel with a biologically active marine exopolysaccharide for cell-based cartilage engineering. |
| Q35465768 | Evaluation of Immunostimulatory Potential of Branded and US-Generic Enoxaparins in an In Vitro Human Immune System Model |
| Q30568524 | Fell-Muir Lecture: Heparan sulphate and the art of cell regulation: a polymer chain conducts the protein orchestra |
| Q46324248 | Fluorophore-assisted carbohydrate electrophoresis for the determination of molecular mass of heparins and low-molecular-weight (LMW) heparins |
| Q37721690 | Fluorous-assisted chemoenzymatic synthesis of heparan sulfate oligosaccharides |
| Q33757403 | Focusing of low-molecular-mass heparins in polycationic polyacrylamide matrices |
| Q43812152 | Generation of anti-factor Xa active, 3-O-sulfated glucosamine-rich sequences by controlled desulfation of oversulfated heparins |
| Q36513995 | Glucuronic acid epimerase is associated with plasma triglyceride and high-density lipoprotein cholesterol levels in Turks |
| Q37784304 | Glucuronyl C5-epimerase an enzyme converting glucuronic acid to iduronic acid in heparan sulfate/heparin biosynthesis |
| Q35672130 | Glycans and neural cell interactions |
| Q26830814 | Glycobiology of human milk |
| Q37623543 | Glycol-split nonanticoagulant heparins are inhibitors of hepcidin expression in vitro and in vivo. |
| Q42076709 | Heparan sulfate separation, sequencing, and isomeric differentiation: ion mobility spectrometry reveals specific iduronic and glucuronic acid-containing hexasaccharides |
| Q38134808 | Heparan sulfate-protein binding specificity |
| Q38311931 | Heparan sulfate-related oligosaccharides in ternary complex formation with fibroblast growth factors 1 and 2 and their receptors |
| Q34351333 | Heparan sulfate: anchor for viral intruders? |
| Q91762127 | Heparanase as an Additional Tool for Detecting Structural Peculiarities of Heparin Oligosaccharides |
| Q47350576 | Heparanase neutralizes the anticoagulation properties of heparin and low-molecular-weight heparin |
| Q92290210 | Heparin Binding Proteins as Therapeutic Target: An Historical Account and Current Trends |
| Q64059120 | Heparin Differentially Impacts Gene Expression of Stromal Cells from Various Tissues |
| Q37151014 | Heparin dodecasaccharide containing two antithrombin-binding pentasaccharides: structural features and biological properties |
| Q38737938 | Heparin regulates B6FS cell motility through a FAK/actin cytoskeleton axis |
| Q37736668 | Heparin-derived heparan sulfate mimics to modulate heparan sulfate-protein interaction in inflammation and cancer |
| Q28280539 | Heparin/heparan sulfate biosynthesis: processive formation of N-sulfated domains |
| Q92152542 | Heparinoid Complex-Based Heparin-Binding Cytokines and Cell Delivery Carriers |
| Q34351342 | Hexuronyl C5-epimerases in alginate and glycosaminoglycan biosynthesis |
| Q37388669 | Identification of candidate cancer-causing genes in mouse brain tumors by retroviral tagging |
| Q37543699 | Interactions between heparan sulfate and proteins-design and functional implications |
| Q64060489 | Introduction to the Molecules Special Edition Entitled '': Some Outstanding Questions in Heparan Sulfate and Heparin Research |
| Q57563789 | Investigating Glycol-Split-Heparin-Derived Inhibitors of Heparanase: A Study of Synthetic Trisaccharides |
| Q40602026 | Involvement of glycosylphosphatidylinositol-linked ceruloplasmin in the copper/zinc-nitric oxide-dependent degradation of glypican-1 heparan sulfate in rat C6 glioma cells |
| Q39146814 | Ion exchange chromatographic separation and isolation of oligosaccharides of intact low-molecular-weight heparin for the determination of their anticoagulant and anti-inflammatory properties |
| Q34289321 | Irreversible glucuronyl C5-epimerization in the biosynthesis of heparan sulfate |
| Q90948634 | Is host heparanase required for the rapid spread of heparan sulfate binding viruses? |
| Q38312237 | Isolation and characterization of low sulfated heparan sulfate sequences with affinity for lipoprotein lipase |
| Q34068498 | Kinetic studies on the interactions of heparin and complement proteins using surface plasmon resonance |
| Q37257393 | Lack of L-iduronic acid in heparan sulfate affects interaction with growth factors and cell signaling |
| Q38362109 | Location of N-unsubstituted glucosamine residues in heparan sulfate |
| Q95271959 | MASP-2 Is a Heparin-Binding Protease; Identification of Blocking Oligosaccharides |
| Q36270533 | Mechanical fibrinogen-depletion supports heparin-free mesenchymal stem cell propagation in human platelet lysate |
| Q35181635 | Mechanisms of glycosaminoglycan activation of the serpins in hemostasis |
| Q33994681 | Microscale isolation and analysis of heparin from plasma using an anion-exchange spin column |
| Q45221614 | Modulation of the heparanase-inhibiting activity of heparin through selective desulfation, graded N-acetylation, and glycol splitting |
| Q38152204 | Molecular engineering of glycosaminoglycan chemistry for biomolecule delivery |
| Q51568879 | Molecular modeling of the interaction between heparan sulfate and cellular growth factors: bringing pieces together. |
| Q41002514 | NDST2 (N-Deacetylase/N-Sulfotransferase-2) Enzyme Regulates Heparan Sulfate Chain Length |
| Q79210669 | Nitrocellulose Filter Binding to Assess Binding of Glycosaminoglycans to Proteins |
| Q38175433 | Non-anticoagulant derivatives of heparin for the management of asthma: distant dream or close reality? |
| Q37379726 | Non-anticoagulant heparins and inhibition of cancer |
| Q38855728 | Old and new applications of non-anticoagulant heparin |
| Q79372181 | Oligosaccharide microarrays to map interactions of carbohydrates in biological systems |
| Q35147247 | Opposing effects of low molecular weight heparins on the release of inflammatory cytokines from peripheral blood mononuclear cells of asthmatics |
| Q37359606 | Orthogonal analytical approaches to detect potential contaminants in heparin |
| Q26823840 | Pathophysiology of heparan sulphate: many diseases, few drugs |
| Q34452632 | Platelet factor 4 inhibits thrombomodulin-dependent activation of thrombin-activatable fibrinolysis inhibitor (TAFI) by thrombin |
| Q89977542 | Potential Mechanisms of Cancer-Related Hypercoagulability |
| Q35746811 | Preparation and characterization of heparin hexasaccharide library with N-unsubstituted glucosamine residues |
| Q73929097 | Preparation and utility of neoproteoglycan probes in analyses of interaction with glycosaminoglycan-binding proteins |
| Q38331584 | Preparation of heparin/heparan sulfate oligosaccharides with internal N-unsubstituted glucosamine residues for functional studies |
| Q38319635 | Profiling glycol-split heparins by high-performance liquid chromatography/mass spectrometry analysis of their heparinase-generated oligosaccharides |
| Q30838810 | Profiling heparin-chemokine interactions using synthetic tools |
| Q38303432 | Profiling sulfation/epimerization pattern of full-length heparan sulfate by NMR following cell culture 13C-glucose metabolic labeling |
| Q42577323 | Residual dipolar coupling investigation of a heparin tetrasaccharide confirms the limited effect of flexibility of the iduronic acid on the molecular shape of heparin |
| Q34361094 | Role of heparan sulfate domain organization in endostatin inhibition of endothelial cell function |
| Q109525076 | SARS-CoV-2 spike protein causes blood coagulation and thrombosis by competitive binding to heparan sulfate |
| Q35656129 | SPECT imaging of peripheral amyloid in mice by targeting hyper-sulfated heparan sulfate proteoglycans with specific scFv antibodies. |
| Q36556537 | Significance of the 2-O-sulfo group of L-iduronic acid residues in heparin on the growth inhibition of bovine pulmonary artery smooth muscle cells |
| Q59813809 | Solution Conformation of Heparin Tetrasaccharide. DFT Analysis of Structure and Spin⁻Spin Coupling Constants |
| Q38324768 | Specific interaction of the envelope glycoproteins E1 and E2 with liver heparan sulfate involved in the tissue tropismatic infection by hepatitis C virus |
| Q38559646 | Stem Cells on Biomaterials for Synthetic Grafts to Promote Vascular Healing |
| Q36822084 | Strategies in synthesis of heparin/heparan sulfate oligosaccharides: 2000-present |
| Q24306149 | Structural recognition by recombinant human heparanase that plays critical roles in tumor metastasis. Hierarchical sulfate groups with different effects and the essential target disulfated trisaccharide sequence |
| Q51806250 | Structural requirements for heparin/heparan sulfate binding to type V collagen. |
| Q34805392 | Structural specificity of heparin binding in the fibroblast growth factor family of proteins |
| Q92370403 | Substrate binding mode and catalytic mechanism of human heparan sulfate d-glucuronyl C5 epimerase |
| Q38357174 | Substrate specificities of mouse heparan sulphate glucosaminyl 6-O-sulphotransferases |
| Q30482247 | Sugar Chips immobilized with synthetic sulfated disaccharides of heparin/heparan sulfate partial structure |
| Q34625346 | Susceptibility of enoxaparin reducing end amino sugars to periodate oxidation |
| Q35783198 | Synergistic Binding of Vascular Endothelial Growth Factor-A and Its Receptors to Heparin Selectively Modulates Complex Affinity |
| Q39590858 | Synthesis and evaluation of xylopyranoside derivatives as "decoy acceptors" of human β-1,4-galactosyltransferase 7. |
| Q34276825 | Synthesis of a heparan sulfate mimetic library targeting FGF and VEGF via click chemistry on a monosaccharide template |
| Q79230764 | Synthesis of heparin-like oligosaccharides on a soluble polymer support |
| Q80866631 | Synthesis of heparin-like oligosaccharides on polymer supports |
| Q39399937 | Targeting heparin and heparan sulfate protein interactions. |
| Q28072373 | The Endothelial Glycocalyx: New Diagnostic and Therapeutic Approaches in Sepsis |
| Q40103047 | The glycosaminoglycan chain of decorin plays an important role in collagen fibril formation at the early stages of fibrillogenesis |
| Q24300738 | The human D-glucuronyl C5-epimerase gene is transcriptionally activated through the beta-catenin-TCF4 pathway |
| Q53634101 | The stereoselectivities of tributyltin hydride-mediated reductions of 5-bromo-D-glucuronides to L-iduronides are dependent on the anomeric substituent: syntheses and DFT calculations. |
| Q33579043 | Towards the assembly of heparin and heparan sulfate oligosaccharide libraries: efficient synthesis of uronic acid and disaccharide building blocks |
| Q81474966 | Transgenic or tumor-induced expression of heparanase upregulates sulfation of heparan sulfate |
| Q40447314 | Two heparanase splicing variants with distinct properties are necessary in early Xenopus development. |
| Q45331274 | Two promoters with distinct activities in different tissues drive the expression of heparanase in Xenopus |
| Q35853992 | Unfractionated heparin attenuates intestinal injury in mouse model of sepsis by inhibiting heparanase |
Search more.